Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
133
Total 13F shares, excl. options
28.3M
Shares change
+5.33M
Total reported value, excl. options
$2.38B
Value change
+$495M
Put/Call ratio
1.54
Number of buys
101
Number of sells
-36
Price
$83.95

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2021

153 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q2 2021.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28.3M shares of 264M outstanding shares and own 10.7% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6.62M shares), Cederberg Capital Ltd (2.05M shares), BlackRock Inc. (1.79M shares), Ward Ferry Management (BVI) Ltd (1.79M shares), Zeal Asset Management Ltd (988K shares), Octagon Capital Advisors LP (943K shares), PRICE T ROWE ASSOCIATES INC /MD/ (845K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (825K shares), PRINCIPAL FINANCIAL GROUP INC (764K shares), and Artal Group S.A. (750K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.